ES2704775T3 - Dispositivos para el despliegue y la liberación de un implante temporal en el cuerpo - Google Patents
Dispositivos para el despliegue y la liberación de un implante temporal en el cuerpo Download PDFInfo
- Publication number
- ES2704775T3 ES2704775T3 ES16191563T ES16191563T ES2704775T3 ES 2704775 T3 ES2704775 T3 ES 2704775T3 ES 16191563 T ES16191563 T ES 16191563T ES 16191563 T ES16191563 T ES 16191563T ES 2704775 T3 ES2704775 T3 ES 2704775T3
- Authority
- ES
- Spain
- Prior art keywords
- release
- fluid
- reservoir
- device assembly
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007943 implant Substances 0.000 title description 7
- 239000000463 material Substances 0.000 claims abstract description 341
- 239000012530 fluid Substances 0.000 claims abstract description 231
- 238000011049 filling Methods 0.000 claims abstract description 62
- 239000000945 filler Substances 0.000 claims abstract description 48
- 238000012546 transfer Methods 0.000 claims abstract description 39
- 230000004888 barrier function Effects 0.000 claims abstract description 24
- 230000015556 catabolic process Effects 0.000 claims abstract description 16
- 238000006731 degradation reaction Methods 0.000 claims abstract description 16
- 230000005012 migration Effects 0.000 claims abstract description 7
- 238000013508 migration Methods 0.000 claims abstract description 7
- 230000009467 reduction Effects 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims description 84
- 238000007789 sealing Methods 0.000 claims description 5
- 230000037361 pathway Effects 0.000 claims description 4
- 239000013013 elastic material Substances 0.000 claims description 3
- 239000000017 hydrogel Substances 0.000 description 67
- 239000000126 substance Substances 0.000 description 55
- 210000002784 stomach Anatomy 0.000 description 53
- 230000002496 gastric effect Effects 0.000 description 51
- 239000010410 layer Substances 0.000 description 49
- 238000000034 method Methods 0.000 description 30
- 229920001610 polycaprolactone Polymers 0.000 description 30
- 239000004632 polycaprolactone Substances 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 230000008961 swelling Effects 0.000 description 20
- 238000010276 construction Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- 238000002844 melting Methods 0.000 description 15
- 230000008018 melting Effects 0.000 description 15
- 230000037406 food intake Effects 0.000 description 14
- 210000001035 gastrointestinal tract Anatomy 0.000 description 14
- 239000010408 film Substances 0.000 description 13
- 230000009471 action Effects 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 230000007246 mechanism Effects 0.000 description 11
- 210000004379 membrane Anatomy 0.000 description 11
- 239000012528 membrane Substances 0.000 description 11
- 239000006186 oral dosage form Substances 0.000 description 11
- 208000008589 Obesity Diseases 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 235000020824 obesity Nutrition 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 238000003466 welding Methods 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 9
- 238000004146 energy storage Methods 0.000 description 9
- 239000002250 absorbent Substances 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 230000000712 assembly Effects 0.000 description 8
- 238000000429 assembly Methods 0.000 description 8
- 239000000560 biocompatible material Substances 0.000 description 8
- 229920000728 polyester Polymers 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- 229920002635 polyurethane Polymers 0.000 description 8
- 239000004814 polyurethane Substances 0.000 description 8
- 230000002745 absorbent Effects 0.000 description 7
- 230000004913 activation Effects 0.000 description 7
- 238000001994 activation Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 229920002401 polyacrylamide Polymers 0.000 description 7
- 230000009747 swallowing Effects 0.000 description 7
- 230000001225 therapeutic effect Effects 0.000 description 7
- 229920002125 Sokalan® Polymers 0.000 description 6
- -1 but not limited to Substances 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 5
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 5
- 229920000299 Nylon 12 Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000001110 calcium chloride Substances 0.000 description 5
- 229910001628 calcium chloride Inorganic materials 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000004584 polyacrylic acid Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 206010033307 Overweight Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000036571 hydration Effects 0.000 description 4
- 238000006703 hydration reaction Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 3
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000005033 polyvinylidene chloride Substances 0.000 description 3
- 238000009958 sewing Methods 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 239000001069 triethyl citrate Substances 0.000 description 3
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 3
- 235000013769 triethyl citrate Nutrition 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
- 229920003141 Eudragit® S 100 Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920002201 Oxidized cellulose Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000003833 bile salt Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001839 endoscopy Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000019525 fullness Nutrition 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 210000001156 gastric mucosa Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000037219 healthy weight Effects 0.000 description 2
- 229920000092 linear low density polyethylene Polymers 0.000 description 2
- 239000004707 linear low-density polyethylene Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 229940107304 oxidized cellulose Drugs 0.000 description 2
- 229920000052 poly(p-xylylene) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 239000003106 tissue adhesive Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- RNIHAPSVIGPAFF-UHFFFAOYSA-N Acrylamide-acrylic acid resin Chemical compound NC(=O)C=C.OC(=O)C=C RNIHAPSVIGPAFF-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- RYECOJGRJDOGPP-UHFFFAOYSA-N Ethylurea Chemical group CCNC(N)=O RYECOJGRJDOGPP-UHFFFAOYSA-N 0.000 description 1
- 229920003143 Eudragit® FS 30 D Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001272720 Medialuna californiensis Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 241000405070 Percophidae Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000030366 Scorpidinae Species 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 229920006378 biaxially oriented polypropylene Polymers 0.000 description 1
- 239000011127 biaxially oriented polypropylene Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000005773 cancer-related death Effects 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000011038 discontinuous diafiltration by volume reduction Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 1
- BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229920001821 foam rubber Polymers 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000030135 gastric motility Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000012977 invasive surgical procedure Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000020442 loss of weight Diseases 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 210000003750 lower gastrointestinal tract Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229920001432 poly(L-lactide) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920006264 polyurethane film Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 229920002397 thermoplastic olefin Polymers 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
- A61F5/004—Intragastrical devices remotely adjustable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
- A61F5/004—Intragastrical devices remotely adjustable
- A61F5/0043—Intragastrical devices remotely adjustable using injection ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0089—Instruments for placement or removal
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nursing (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Prostheses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261601384P | 2012-02-21 | 2012-02-21 | |
| US201261645601P | 2012-05-10 | 2012-05-10 | |
| US201261647730P | 2012-05-16 | 2012-05-16 | |
| US201261663433P | 2012-06-22 | 2012-06-22 | |
| US201261663682P | 2012-06-25 | 2012-06-25 | |
| US201261663683P | 2012-06-25 | 2012-06-25 | |
| US201261674126P | 2012-07-20 | 2012-07-20 | |
| US201261699942P | 2012-09-12 | 2012-09-12 | |
| US201361762196P | 2013-02-07 | 2013-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2704775T3 true ES2704775T3 (es) | 2019-03-19 |
Family
ID=48982832
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16191563T Active ES2704775T3 (es) | 2012-02-21 | 2013-02-21 | Dispositivos para el despliegue y la liberación de un implante temporal en el cuerpo |
| ES13752472.4T Active ES2608629T3 (es) | 2012-02-21 | 2013-02-21 | Dispositivos para el despliegue y la liberación de un implante temporal en el cuerpo |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13752472.4T Active ES2608629T3 (es) | 2012-02-21 | 2013-02-21 | Dispositivos para el despliegue y la liberación de un implante temporal en el cuerpo |
Country Status (15)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6219776B1 (en) | 1998-03-10 | 2001-04-17 | Billions Of Operations Per Second | Merged array controller and processing element |
| WO2009096873A1 (en) * | 2008-01-29 | 2009-08-06 | Milux Holding Sa | Methods and instruments for treating gerd |
| US8162969B2 (en) | 2008-10-16 | 2012-04-24 | Obalon Therapeutics, Inc. | Intragastric device |
| CA2865056C (en) | 2012-02-21 | 2021-07-20 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| US9849018B2 (en) | 2012-02-21 | 2017-12-26 | Allurion Technologies, Inc. | Ingestible delivery systems and methods |
| US8974483B2 (en) | 2012-02-21 | 2015-03-10 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| US10182932B2 (en) | 2012-02-21 | 2019-01-22 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| CN104334123B (zh) * | 2012-06-07 | 2019-02-12 | 意比图密医疗有限公司 | 膨胀装置 |
| WO2015034088A1 (ja) * | 2013-09-06 | 2015-03-12 | 株式会社 エム光・エネルギー開発研究所 | 撥液性多孔質膜を備えた電気化学反応装置 |
| US10058647B2 (en) * | 2013-10-04 | 2018-08-28 | President And Fellows Of Harvard College | Biomimetic actuation device and system, and methods for controlling a biomimetic actuation device and system |
| EP3062749B1 (en) * | 2013-11-01 | 2020-12-02 | Allurion Technologies, Inc. | Devices for deploying and releasing a temporary implant within the body |
| ES2869024T3 (es) * | 2013-11-08 | 2021-10-22 | Hollister Inc | Catéteres oleófilos lubricados |
| BR112016012615B1 (pt) | 2013-12-05 | 2023-02-07 | Epitomee Medical Ltd | Sistemas, e kit |
| ES2525771B1 (es) * | 2014-09-26 | 2015-05-14 | Ramón ABAD BELANDO | Dispositivo introductor de balón hinchable |
| EP3268079A4 (en) * | 2015-03-09 | 2018-09-19 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| EP3173034B1 (de) * | 2015-11-30 | 2018-10-17 | Universitätsklinikum Halle (Saale) | Vorrichtung für die durchführung von organokklusionen, insbesondere einer intrauterinen trachealokklusion bei der behandlung einer angeborenen fetalen zwerchfellhernie |
| US10350100B2 (en) * | 2016-04-12 | 2019-07-16 | Obalon Therapeutics, Inc. | System for detecting an intragastric balloon |
| JP7261160B2 (ja) * | 2016-11-23 | 2023-04-19 | ホロジック， インコーポレイテッド | 生検部位マーカー |
| US10548753B2 (en) | 2017-01-13 | 2020-02-04 | Ethicon, Inc. | Passive caloric bypass device |
| US10537454B2 (en) | 2017-06-16 | 2020-01-21 | Proximate Concepts Llc | Electrophysiologically active transducer intragastric balloon system and method |
| WO2019022982A1 (en) * | 2017-07-26 | 2019-01-31 | Verily Life Sciences Llc | INGREDIENT INTRAGASTRIC BALLOON |
| EP3703659B1 (en) * | 2017-10-31 | 2024-08-21 | Tusker Medical, Inc. | Systems for delivery of therapeutic substance to nasal cavity |
| WO2019112768A1 (en) * | 2017-12-07 | 2019-06-13 | Obalon Therapeutics, Inc. | Intragastric device with self-deflation |
| WO2019165449A1 (en) | 2018-02-26 | 2019-08-29 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
| IT201800006814A1 (it) * | 2018-06-29 | 2019-12-29 | Espansore per endoprotesi ortotopica di vescica artificiale | |
| CN112638464B (zh) | 2018-07-06 | 2021-12-14 | 阿勒里恩科技公司 | 二元流体控制阀系统 |
| US11160677B2 (en) | 2018-09-05 | 2021-11-02 | Ethicon, Inc. | Apparatus and method for gastric volume reduction utilizing an expandable member |
| BR112021011198A2 (pt) | 2018-12-13 | 2021-08-31 | Allurion Technologies, Inc. | Dispositivo médico para posicionamento em um paciente, sistema de distribuição de fluido para posicionar um dispositivo médico em um paciente e distribuir um fluido a um reservatório encerrado no dispositivo e sistema de distribuição de fluido para colocar um dispositivo médico em um paciente e distribuir um fluido a um reservatório encerrado no dispositivo |
| JP6722965B1 (ja) * | 2020-03-17 | 2020-07-15 | エースメディック株式会社 | 液状薬剤浸透装置の補助装置及び液状薬剤浸透システム |
| US20240210310A1 (en) * | 2021-03-31 | 2024-06-27 | Kulia Labs, Inc. | Portable hyperspectral system |
| US12246163B2 (en) | 2023-04-12 | 2025-03-11 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
| US12245962B2 (en) | 2023-04-12 | 2025-03-11 | Allurion Technologies, Inc. | Balloon sealing and fill valve |
| EP4458883A1 (en) | 2023-05-05 | 2024-11-06 | Pablo Hernan Somorrostro Spezzi | Polysaccharide composition and gastric balloon formed from such composition |
Family Cites Families (96)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2911988A (en) | 1956-01-24 | 1959-11-10 | Clarence J Ravn | Moisture releasable drain valve |
| US3586018A (en) | 1969-02-24 | 1971-06-22 | Thermia Verken Ab | Self-closing valve |
| US3853116A (en) * | 1971-06-21 | 1974-12-10 | Investors In Ventures Inc | Implant methods and devices for influencing body fluids |
| GB1577517A (en) | 1976-04-28 | 1980-10-22 | Ici Ltd | Method of thermoforming |
| US4133315A (en) | 1976-12-27 | 1979-01-09 | Berman Edward J | Method and apparatus for reducing obesity |
| DE2935631A1 (de) | 1979-09-04 | 1981-04-16 | Plate Bonn Gmbh, 5300 Bonn | Mehrschicht-kunststoff-folie, verfahren zu ihrer herstellung und deren verwendung |
| US4899747A (en) * | 1981-12-10 | 1990-02-13 | Garren Lloyd R | Method and appartus for treating obesity |
| US4723547A (en) * | 1985-05-07 | 1988-02-09 | C. R. Bard, Inc. | Anti-obesity balloon placement system |
| US4739758A (en) | 1986-05-19 | 1988-04-26 | Criticare Systems, Inc. | Apparatus for stomach cavity reduction |
| US4949756A (en) | 1988-08-31 | 1990-08-21 | Uresil Corporation | One-way valve |
| US4842007A (en) * | 1988-09-08 | 1989-06-27 | Guard Associates, Inc. | Self-sealing valve for inflated bodies |
| JP2514087Y2 (ja) * | 1990-05-25 | 1996-10-16 | 幸三 牧田 | 離脱式両端逆止弁付きバル―ン |
| JPH0559611A (ja) | 1991-08-28 | 1993-03-09 | Unitika Ltd | 高強度ポリカプロラクトンモノフイラメントとその製造法 |
| US5336123A (en) * | 1992-04-08 | 1994-08-09 | Vonco Products, Inc. | Inflatable flexible pouch |
| US5348537A (en) | 1992-07-15 | 1994-09-20 | Advanced Cardiovascular Systems, Inc. | Catheter with intraluminal sealing element |
| US5482492A (en) * | 1994-01-10 | 1996-01-09 | M & D Balloons, Inc. | Balloons and balloon valves |
| US5496203A (en) | 1994-03-25 | 1996-03-05 | Murray; Robert H. | Balloon valve assembly |
| US5507808A (en) | 1994-10-26 | 1996-04-16 | Becker; Hilton | Filling tube and seal construction |
| US5884625A (en) | 1996-07-09 | 1999-03-23 | Hart; William T. | Oral appliance for delivering gas to the retroglossal area |
| US6129751A (en) | 1998-07-28 | 2000-10-10 | Intermedics Inc. | Cardiac lead with active fixation and biocompatible lubricant |
| AUPP550098A0 (en) | 1998-08-26 | 1998-09-17 | Microcatheters Pty Ltd | Catheter guide |
| US6162251A (en) | 1999-05-25 | 2000-12-19 | Novamed Medical Products Manufacturing, Inc. | Saline implant having single valve with primary and secondary closures |
| US20040101540A1 (en) | 1999-09-01 | 2004-05-27 | John Cooker | Oral delivery system and method for making same |
| FR2805986B1 (fr) * | 2000-03-13 | 2002-10-11 | Districlass Madical | Dispositif intra-gastrique a volume variable |
| US6682473B1 (en) | 2000-04-14 | 2004-01-27 | Solace Therapeutics, Inc. | Devices and methods for attenuation of pressure waves in the body |
| US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US7837720B2 (en) * | 2000-06-20 | 2010-11-23 | Boston Scientific Corporation | Apparatus for treatment of tissue adjacent a bodily conduit with a gene or drug-coated compression balloon |
| US6460541B1 (en) | 2000-11-07 | 2002-10-08 | Polyzen, Inc. | Heat-sealed inflatable article, and method of making the same |
| US6537247B2 (en) | 2001-06-04 | 2003-03-25 | Donald T. Shannon | Shrouded strain relief medical balloon device and method of use |
| US6644336B2 (en) | 2001-06-12 | 2003-11-11 | Oil States Industries, Inc. | Method and apparatus for automatic shutoff of a valve when a substance is present in a flow of fluid |
| US6939292B2 (en) | 2001-06-20 | 2005-09-06 | Olympus Corporation | Capsule type endoscope |
| US7160258B2 (en) | 2001-06-26 | 2007-01-09 | Entrack, Inc. | Capsule and method for treating or diagnosing the intestinal tract |
| US20040146559A1 (en) | 2002-09-28 | 2004-07-29 | Sowden Harry S. | Dosage forms having an inner core and outer shell with different shapes |
| US6712832B2 (en) | 2001-10-15 | 2004-03-30 | Tilak M. Shah | Low-pressure medical balloons and method of making same |
| US7485093B2 (en) | 2002-04-25 | 2009-02-03 | Given Imaging Ltd. | Device and method for in-vivo sensing |
| US20040192582A1 (en) | 2002-12-19 | 2004-09-30 | Burnett Daniel R. | Ingestible formulations for transient, noninvasive reduction of gastric volume |
| US6981980B2 (en) | 2003-03-19 | 2006-01-03 | Phagia Technology | Self-inflating intragastric volume-occupying device |
| PT1638638E (pt) * | 2003-06-20 | 2009-09-09 | Allergan Inc | Válvula de ranhura de duas vias |
| RU2338561C2 (ru) * | 2003-06-20 | 2008-11-20 | Аллерган, Инк. | Клапан с пазом и медицинский аппарат для лечения ожирения |
| US9498366B2 (en) * | 2003-07-28 | 2016-11-22 | Baronova, Inc. | Devices and methods for pyloric anchoring |
| MX2007001819A (es) | 2004-08-13 | 2008-03-19 | Phagia Technology | Dispositivo que ocupa volumen intragastrico. |
| US20080275569A1 (en) * | 2004-09-16 | 2008-11-06 | Evera Medical, Inc | Tissue Augmentation Device |
| US7641688B2 (en) | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
| US20070078476A1 (en) | 2004-10-12 | 2007-04-05 | Hull Wendell C Sr | Overweight control apparatuses for insertion into the stomach |
| RU2386455C2 (ru) * | 2004-10-15 | 2010-04-20 | БиЭфКейДаблЮ, ЭлЭлСи | Устройство и способ для лечения от ожирения |
| US20080269555A1 (en) * | 2005-02-24 | 2008-10-30 | Compagnie Europeenne D'etude Et De Recherche De Di Spositifs Pour L'lmplantation Par Laparoscopie | Intragastric Balloon With Extraction Reinforcement |
| US20060222705A1 (en) | 2005-03-31 | 2006-10-05 | Flanner Henry H | Pharmaceutical tablet and apparatus and method for making |
| BRPI0520316A2 (pt) | 2005-06-01 | 2009-05-05 | Cie Euro Etude Rech Paroscopie | balão intra-gástrico contendo gel e provido com válvula para ser implantado no estÈmago de um paciente com o propósito de reduzir o volume do estÈmago como modo de tratamento da obesidade e kit e uso deste |
| EP1741464A3 (en) * | 2005-07-07 | 2007-04-25 | Bristol-Myers Squibb Company | One-way valve for an inflatable chamber of a medical device |
| CA2925648A1 (en) | 2005-10-31 | 2007-05-10 | Reshape Medical, Inc. | Intragastric space filler with safety device |
| US20110112383A1 (en) | 2005-11-08 | 2011-05-12 | Plensat, Inc | Devices, systems and methods for treatment of eating disorders |
| WO2008030403A1 (en) | 2006-09-02 | 2008-03-13 | Synecor, Llc | Intestinal sleeves and associated deployment systems and methods |
| US20080183128A1 (en) | 2007-01-24 | 2008-07-31 | John Morriss | Methods, devices and systems for treatment and/or diagnosis of disorders of the ear, nose and throat |
| US8585676B2 (en) | 2007-02-05 | 2013-11-19 | Polyzen Inc. | Multi-lumen lay-flat tubing, catheter articles comprising same, and method of manufacture thereof |
| JP5259966B2 (ja) | 2007-03-26 | 2013-08-07 | 株式会社ジェイ・エム・エス | 口腔関連圧力測定用バルーンおよびその製造方法 |
| US8226602B2 (en) | 2007-03-30 | 2012-07-24 | Reshape Medical, Inc. | Intragastric balloon system and therapeutic processes and products |
| US20080249635A1 (en) * | 2007-04-05 | 2008-10-09 | Barry Weitzner | Gastric filler devices for obesity therapy |
| US20080255601A1 (en) * | 2007-04-13 | 2008-10-16 | Allergan, Inc. | Apparatus and method for remote deflation of intragastric balloon |
| US7976497B2 (en) | 2007-09-25 | 2011-07-12 | Polyzen Inc. | Multi-layer film welded articulated balloon |
| WO2009059803A1 (en) | 2007-11-09 | 2009-05-14 | Venera Khafizova | Externally inflatable gastric balloon device |
| WO2009059802A1 (en) * | 2007-11-09 | 2009-05-14 | Venera Khafizova | Self-deflating gastric balloon device |
| WO2009086119A2 (en) * | 2007-12-20 | 2009-07-09 | 7L, Llc | Swallowable self-expanding gastric space occupying device |
| US20090259246A1 (en) | 2008-04-14 | 2009-10-15 | Sherif Eskaros | Intragastric Volume-Occupying Device |
| US8377128B2 (en) | 2008-04-28 | 2013-02-19 | Allergan, Inc. | Flush patch for elastomeric implant shell |
| US20100241152A1 (en) | 2008-06-02 | 2010-09-23 | Loma Vista Medical, Inc. | Inflatable medical devices |
| US20100062057A1 (en) | 2008-09-10 | 2010-03-11 | Pronova BioPharma Norge AS. | Formulation |
| US8162969B2 (en) * | 2008-10-16 | 2012-04-24 | Obalon Therapeutics, Inc. | Intragastric device |
| US20100114311A1 (en) | 2008-11-05 | 2010-05-06 | Hilton Becker | Multi-Lumen Breast Prothesis and Improved Valve Assembly Therefor |
| US20100246165A1 (en) | 2009-03-31 | 2010-09-30 | Diaz Edmundo B | Invisible and/ or non-invisible designed inflatables combined with electric black ultra-violet lights and inflator nozzle fixture accessories |
| US20110004236A1 (en) | 2009-07-01 | 2011-01-06 | E2 Llc | Systems and Methods for Treating Obesity and Type 2 Diabetes |
| US8608642B2 (en) * | 2010-02-25 | 2013-12-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for treating morbid obesity using hydrogel |
| US9592119B2 (en) | 2010-07-13 | 2017-03-14 | C.R. Bard, Inc. | Inflatable medical devices |
| US8870966B2 (en) | 2010-10-18 | 2014-10-28 | Apollo Endosurgery, Inc. | Intragastric balloon for treating obesity |
| US8383135B2 (en) | 2010-12-03 | 2013-02-26 | Richard C. Fuisz | Solid dosage form that promotes reliable oral, esophageal and GI transit |
| US20120141544A1 (en) | 2010-12-03 | 2012-06-07 | Fuisz Richard C | Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit |
| CN201977967U (zh) * | 2011-01-18 | 2011-09-21 | 郭加 | 一种减肥用胃内填充球装置 |
| US8292911B2 (en) | 2011-01-21 | 2012-10-23 | Obalon Therapeutics, Inc. | Intragastric device |
| EP3284504B1 (en) | 2011-01-21 | 2020-06-03 | Obalon Therapeutics, Inc. | Intragastric device |
| US8202291B1 (en) | 2011-01-21 | 2012-06-19 | Obalon Therapeutics, Inc. | Intragastric device |
| US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
| US9849018B2 (en) | 2012-02-21 | 2017-12-26 | Allurion Technologies, Inc. | Ingestible delivery systems and methods |
| US10182932B2 (en) | 2012-02-21 | 2019-01-22 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| CA2865056C (en) | 2012-02-21 | 2021-07-20 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| US8974483B2 (en) | 2012-02-21 | 2015-03-10 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| CA2867440C (en) | 2012-03-29 | 2018-12-11 | Trudell Medical International | Oral device with bolus simulator and method of use thereof |
| WO2014040064A1 (en) | 2012-09-10 | 2014-03-13 | Boston Scientific Scimed, Inc. | Catheter with releasable balloon and related methods |
| EP3062749B1 (en) | 2013-11-01 | 2020-12-02 | Allurion Technologies, Inc. | Devices for deploying and releasing a temporary implant within the body |
| US9822886B2 (en) | 2014-10-15 | 2017-11-21 | Baker Products, Ltd. | Temperature controlled purge valve with washer/O-ring seal stack |
| EP3268079A4 (en) | 2015-03-09 | 2018-09-19 | Allurion Technologies, Inc. | Methods and devices for deploying and releasing a temporary implant within the body |
| US20170211715A1 (en) | 2016-01-21 | 2017-07-27 | GM Global Technology Operations LLC | Oil bypass valve with temporary spacer to provide initially opened fluid circuit |
| WO2017136840A1 (en) | 2016-02-05 | 2017-08-10 | Allurion Technologies, Inc. | Method of fabrication for devices for deploying and releasing a temporary implant within the body |
| US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| JP6222763B1 (ja) | 2017-01-31 | 2017-11-01 | 日本ライフライン株式会社 | バルーンカテーテル |
| US20180311484A1 (en) | 2017-05-01 | 2018-11-01 | Allurion Technologies, Inc. | Method of fabrication for devices for deploying and releasing a temporary implant within the body |
| WO2019165449A1 (en) | 2018-02-26 | 2019-08-29 | Allurion Technologies, Inc. | Automatic-sealing balloon-filling catheter system |
| CN112638464B (zh) | 2018-07-06 | 2021-12-14 | 阿勒里恩科技公司 | 二元流体控制阀系统 |
-
2013
- 2013-02-21 CA CA2865056A patent/CA2865056C/en active Active
- 2013-02-21 MX MX2017009273A patent/MX385865B/es unknown
- 2013-02-21 AU AU2013222419A patent/AU2013222419B2/en active Active
- 2013-02-21 US US13/773,516 patent/US8870907B2/en active Active
- 2013-02-21 MX MX2014009878A patent/MX349195B/es active IP Right Grant
- 2013-02-21 EP EP16191563.2A patent/EP3189817B1/en active Active
- 2013-02-21 RU RU2014137127/14A patent/RU2601995C2/ru active
- 2013-02-21 CN CN201380010418.4A patent/CN104168945B/zh active Active
- 2013-02-21 ES ES16191563T patent/ES2704775T3/es active Active
- 2013-02-21 ES ES13752472.4T patent/ES2608629T3/es active Active
- 2013-02-21 EP EP18200780.7A patent/EP3494938A1/en not_active Withdrawn
- 2013-02-21 KR KR1020147026333A patent/KR101872064B1/ko active Active
- 2013-02-21 WO PCT/US2013/027170 patent/WO2013126593A1/en active Application Filing
- 2013-02-21 IN IN7768DEN2014 patent/IN2014DN07768A/en unknown
- 2013-02-21 EP EP13752472.4A patent/EP2817062B1/en active Active
- 2013-02-21 JP JP2014557889A patent/JP6311936B2/ja active Active
- 2013-02-21 BR BR112014020188-9A patent/BR112014020188B1/pt active IP Right Grant
- 2013-02-21 SG SG11201404821UA patent/SG11201404821UA/en unknown
- 2013-05-23 US US13/901,338 patent/US8814898B2/en active Active
-
2014
- 2014-06-10 US US14/301,210 patent/US9387107B2/en active Active
- 2014-08-14 IL IL234139A patent/IL234139B/en active IP Right Grant
-
2016
- 2016-06-06 US US15/174,864 patent/US9827129B2/en active Active
-
2017
- 2017-06-28 AU AU2017204386A patent/AU2017204386B2/en active Active
- 2017-10-25 US US15/793,526 patent/US10786379B2/en active Active
-
2018
- 2018-11-07 IL IL262857A patent/IL262857A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2704775T3 (es) | Dispositivos para el despliegue y la liberación de un implante temporal en el cuerpo | |
| US8974483B2 (en) | Methods and devices for deploying and releasing a temporary implant within the body | |
| CN110448398B (zh) | 展开和释放身体内的临时移植物的方法和设备 | |
| WO2014074625A1 (en) | Anatomically adapted ingestible delivery systems and methods | |
| EP3268079A1 (en) | Methods and devices for deploying and releasing a temporary implant within the body | |
| EP2916904B1 (en) | Anatomically adapted ingestible delivery systems | |
| BR112017019394B1 (pt) | Dispositivo médico |